151 related articles for article (PubMed ID: 15743776)
1. Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.
Judex MO; Mueller BM
Am J Pathol; 2005 Mar; 166(3):645-7. PubMed ID: 15743776
[TBL] [Abstract][Full Text] [Related]
2. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
[TBL] [Abstract][Full Text] [Related]
3. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
Li J; Ny A; Leonardsson G; Nandakumar KS; Holmdahl R; Ny T
Am J Pathol; 2005 Mar; 166(3):783-92. PubMed ID: 15743790
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Pakozdi A; Amin MA; Haas CS; Martinez RJ; Haines GK; Santos LL; Morand EF; David JR; Koch AE
Arthritis Res Ther; 2006; 8(4):R132. PubMed ID: 16872482
[TBL] [Abstract][Full Text] [Related]
5. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.
Busso N; Hamilton JA
Arthritis Rheum; 2002 Sep; 46(9):2268-79. PubMed ID: 12355473
[No Abstract] [Full Text] [Related]
6. [Plasminogen activation and regulation of fibrinolysis].
Madoiwa S
Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
[TBL] [Abstract][Full Text] [Related]
8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
9. HIF-2α-induced chemokines stimulate motility of fibroblast-like synoviocytes and chondrocytes into the cartilage-pannus interface in experimental rheumatoid arthritis mouse models.
Huh YH; Lee G; Lee KB; Koh JT; Chun JS; Ryu JH
Arthritis Res Ther; 2015 Oct; 17():302. PubMed ID: 26510617
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.
Chang SK; Gu Z; Brenner MB
Immunol Rev; 2010 Jan; 233(1):256-66. PubMed ID: 20193004
[TBL] [Abstract][Full Text] [Related]
12. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis.
Franz JK; Pap T; Hummel KM; Nawrath M; Aicher WK; Shigeyama Y; Müller-Ladner U; Gay RE; Gay S
Arthritis Rheum; 2000 Mar; 43(3):599-607. PubMed ID: 10728754
[TBL] [Abstract][Full Text] [Related]
13. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis.
Tomita T; Kunugiza Y; Tomita N; Takano H; Morishita R; Kaneda Y; Yoshikawa H
Int J Mol Med; 2006 Aug; 18(2):257-65. PubMed ID: 16820932
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts.
Gonzalez-Gronow M; Gawdi G; Pizzo SV
J Biol Chem; 1993 Oct; 268(28):20791-5. PubMed ID: 8407906
[TBL] [Abstract][Full Text] [Related]
15. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
[TBL] [Abstract][Full Text] [Related]
16. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
18. Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts.
Serratì S; Margheri F; Chillà A; Neumann E; Müller-Ladner U; Benucci M; Fibbi G; Del Rosso M
Arthritis Rheum; 2011 Sep; 63(9):2584-94. PubMed ID: 21547898
[TBL] [Abstract][Full Text] [Related]
19. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
20. The fibrinolytic system and its relation to inflammatory diseases.
Clemmensen I; Andersen RB
Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
